HyperHep B (hepatitis b immunoglobulin (human)) / Grifols - LARVOL DELTA

Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus. (PubMed, Antiviral Res) - "In vivo studies showed improved reduction of circulating HBsAg in a chronic stage as compared to HyperHEP B. The novel polyclonal antibody therapeutic GIGA-2339 potently binds and neutralizes HBsAg to prevent viral infection and to reduce circulating antigen. GIGA-2339 represents an important new therapeutic modality for the CHB treatment landscape and is currently in clinical development."

Journal • Hepatitis B • Infectious Disease • Inflammation

Grifols introduces HyperHEP B (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B (PRNewswire) - "Grifols...began commercializing HyperHEP B, a new formulation of its hepatitis B immune globulin [human] for hepatitis B postexposure prophylaxis...HyperHEP B will now be available to U.S. healthcare providers and patients in three sizes (0.5 mL neonatal syringe, 1 mL vial, and 5 mL vial) through all major distributors."

Launch US • Hepatitis B • Infectious Disease

"$GRFS $GIKLY Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B https://t.co/iCxIbX3HPm" (,@stock_titan)

Clinical • Hepatitis B • Hepatology • Infectious Disease • Inflammation